These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1884445)

  • 1. Adenosine as a vasodilator in primary pulmonary hypertension.
    Morgan JM; McCormack DG; Griffiths MJ; Morgan CJ; Barnes PJ; Evans TW
    Circulation; 1991 Sep; 84(3):1145-9. PubMed ID: 1884445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and selective reduction of pulmonary vascular resistance in primary pulmonary hypertension.
    Reeves JT; Groves BM; Weir EK
    Circulation; 1991 Sep; 84(3):1437-9. PubMed ID: 1884466
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine is a selective pulmonary vasodilator in cardiac surgical patients.
    Fullerton DA; Kirson LE; Jones SD; McIntyre RC
    Chest; 1996 Jan; 109(1):41-6. PubMed ID: 8549214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
    Cheng D; Chen W; Jiang J
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of infused adenosine on cardiac output and systemic resistance in normal subjects.
    Bush A; Busst CM; Clarke B; Barnes PJ
    Br J Clin Pharmacol; 1989 Feb; 27(2):165-71. PubMed ID: 2713212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S; Schrader BJ; Kaufmann E; Vestal RE; Rich S
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of adenosine and nifedipine in pulmonary hypertension.
    Schrader BJ; Inbar S; Kaufmann L; Vestal RE; Rich S
    J Am Coll Cardiol; 1992 Apr; 19(5):1060-4. PubMed ID: 1552096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
    Ricci GL; Melgosa MT; Burgos F; Valera JL; Pizarro S; Roca J; Rodriguez-Roisin R; Barberà JA
    Liver Transpl; 2007 Nov; 13(11):1506-14. PubMed ID: 17969197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.
    Ooi H; Colucci WS; Givertz MM
    Circulation; 2002 Sep; 106(13):1618-21. PubMed ID: 12270852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.
    Nootens M; Schrader B; Kaufmann E; Vestal R; Long W; Rich S
    Chest; 1995 Jan; 107(1):54-7. PubMed ID: 7813311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M; Ishii Y; Kitamura S; Ohno S
    Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension.
    Eysmann SB; Palevsky HI; Reichek N; Hackney K; Douglas PS
    Chest; 1991 May; 99(5):1066-71. PubMed ID: 2019158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.
    Rossi R; Coppi F; Sgura F; Monopoli D; Boriani G
    Pulm Pharmacol Ther; 2018 Apr; 49():147-151. PubMed ID: 28642014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.
    Cailes J; Winter S; du Bois RM; Evans TW
    Chest; 1998 Jul; 114(1):178-84. PubMed ID: 9674467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension.
    Brett SJ; Simon J; Gibbs R; Pepper JR; Evans TW
    Thorax; 1996 Jan; 51(1):89-91. PubMed ID: 8658378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P; Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.
    Blumberg FC; Riegger GA; Pfeifer M
    Chest; 2002 May; 121(5):1566-71. PubMed ID: 12006445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vascular resistance in neonatal swine: response to right pulmonary artery occlusion, isoproterenol, and prostaglandin E1.
    Crombleholme TM; Adzick NS; Longaker MT; Bradley SM; Duncan BW; Jennings R; Verrier ED; Harrison MR
    J Pediatr Surg; 1990 Aug; 25(8):861-6. PubMed ID: 2401941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.